Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Quest Diagnostics Inc (DGX)
Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,169,729
  • Shares Outstanding, K 112,435
  • Annual Sales, $ 9,883 M
  • Annual Income, $ 946,000 K
  • 60-Month Beta 0.91
  • Price/Sales 1.53
  • Price/Cash Flow 9.68
  • Price/Book 2.39
Trade DGX with:

Options Overview Details

View History
  • Implied Volatility 18.06% ( +0.32%)
  • Historical Volatility 20.78%
  • IV Percentile 24%
  • IV Rank 21.12%
  • IV High 28.19% on 03/15/23
  • IV Low 15.34% on 11/22/23
  • Put/Call Vol Ratio 0.80
  • Today's Volume 74
  • Volume Avg (30-Day) 845
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 21,541
  • Open Int (30-Day) 20,839

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 2.15
  • Number of Estimates 9
  • High Estimate 2.20
  • Low Estimate 2.11
  • Prior Year 1.98
  • Growth Rate Est. (year over year) +8.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
131.42 +2.89%
on 11/10/23
137.61 -1.74%
on 12/04/23
+2.34 (+1.76%)
since 11/07/23
3-Month
119.59 +13.07%
on 10/02/23
137.61 -1.74%
on 12/04/23
+8.11 (+6.38%)
since 09/07/23
52-Week
119.59 +13.07%
on 10/02/23
158.34 -14.60%
on 12/29/22
-13.78 (-9.25%)
since 12/07/22

Most Recent Stories

More News
Firing on All Cylinders Indeed

Investors are seeing some big reactions to earnings results in tech and have a few reasons to think some beaten-up names might be finding their footing.

SBUX : 96.44 (-0.60%)
AAPL : 194.27 (+1.01%)
ROKU : 100.68 (-1.64%)
MTCH : 32.24 (-1.86%)
DASH : 98.97 (+2.19%)
F : 10.82 (+1.22%)
GM : 33.51 (+1.82%)
DGX : 135.22 (+0.22%)
STLA : 22.55 (+0.04%)
KLG : 11.65 (+0.69%)
Quest Diagnostics: Q3 Earnings Snapshot

Quest Diagnostics: Q3 Earnings Snapshot

DGX : 135.22 (+0.22%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1309 (-8.33%)
TELO.VN : 0.180 (unch)
GH : 26.26 (+2.02%)
NTRA : 57.94 (+0.07%)
DGX : 135.22 (+0.22%)
NEO : 17.94 (-1.37%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

/PRNewswire/ -- Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight...

TELO.VN : 0.180 (unch)
TDSGF : 0.1309 (-8.33%)
GH : 26.26 (+2.02%)
NTRA : 57.94 (+0.07%)
DGX : 135.22 (+0.22%)
NEO : 17.94 (-1.37%)
Neway Forms Lab Services Agreement with Quest Diagnostics to Speed Quality ESRD Testing

/PRNewswire/ -- Neway, LLC, the U.S. leader in value-based dialysis lab care, today announced a strategic lab services arrangement with Quest Diagnostics...

DGX : 135.22 (+0.22%)
Quest Diagnostics to Release Third Quarter 2023 Financial Results on October 24, 2023

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report...

DGX : 135.22 (+0.22%)
Quest Diagnostics to Speak at the Baird 2023 Global Healthcare Conference

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Sam Samad,...

DGX : 135.22 (+0.22%)
Quest Diagnostics Releases 2022 Corporate Responsibility Report

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leader in diagnostic information services, today released its 2022 Corporate Responsibility Report. The...

DGX : 135.22 (+0.22%)
Quest Diagnostics Granted FDA Breakthrough Designation for its Adeno-associated virus (AAV) Test

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that its AAVrh74 ELISA assay...

SRPT : 88.41 (+1.18%)
DGX : 135.22 (+0.22%)
Making Connections To Care: Quest Supports Inspiring Health Equity Event Hosted by Sisters on the Vineyard

NORTHAMPTON, MA / ACCESSWIRE / August 28, 2023 / Quest Diagnostics

DGX : 135.22 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 137.31
2nd Resistance Point 136.53
1st Resistance Point 135.88
Last Price 135.22
1st Support Level 134.44
2nd Support Level 133.66
3rd Support Level 133.01

See More

52-Week High 158.34
Fibonacci 61.8% 143.53
Fibonacci 50% 138.96
Last Price 135.22
Fibonacci 38.2% 134.39
52-Week Low 119.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar